Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO)

Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 33
+0.06
+4.7244%
After Hours
$
1. 33
0 0%
87.75M Market Cap
- P/E Ratio
- Div Yield
2.63M Volume
- Eps
$ 1.27
Previous Close
Add Transaction
Day Range
1.22 1.34
Year Range
0.56 2.98
Want to track INO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Inovio Pharmaceuticals, Inc. (INO) Statistics

Valuation metrics

Market Cap 87.75M
Enterprise value 65.6M
Trailing P/E (ttm) -1.11
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 24.09
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.01

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.7M
Average volume (90 days) 1.79M

Price summary

52-Week low 0.56
52-Week high 2.98
Beta -
50-Day moving average 1.01
200-Day moving average 1.4

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 16 Oct 2017
Ex-Dividend Date 28 Sep 2017
Last split factor 1:12
Last split Date 25 Jan 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.37%
Return on equity -10.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.83
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.45
Total debt (mrq) -
Total Debt/Equity (mrq) 1.83
Current ratio (mrq) 1%
Book value per share (mrq) 0.05

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -